Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in South India

Indian Journal of Ophthalmology

Volumn 50, Issue 4, 2002, Pages 283-286

  Kompella, Viswanadh B ^a   Sangwan, Virender S ^a   Bansal, Aashish K ^a   Garg, Prashant ^a   Aasuri, Murali K ^a   Rao, Gullapalli N ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

Complications; Erythema multiforme major; Management; Stevens Johnson syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPYRETIC AGENT; BARBITURIC ACID DERIVATIVE; DAPSONE; PENICILLIN DERIVATIVE; SULFONAMIDE;

ADULT; BLEPHARITIS; CONJUNCTIVA DISEASE; CORNEA DISEASE; DRY EYE; ENTROPION; EYE DISEASE; EYELID DISEASE; EYELID EDEMA; FEMALE; FEVER; HUMAN; IMMUNOMODULATION; INDIA; KERATITIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; QUALITY OF LIFE; REVIEW; SCAR FORMATION; STEVENS JOHNSON SYNDROME; SYMBLEPHARON; SYMPTOMATOLOGY; TRICHIASIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INDIA; INFANT; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036911434     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS. Analysis of acute ophthalmic manifestations of erythema multiforme/Stevens Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995;102:1669-76.
2. Arstikatis MJ. Ocular aftermath of Stevens Johnson syndrome: Review of 33 cases. Ophthalmology 1973;90:376-79.
3. Rasmussen JE. Erythema multiforme in children. Response to treatment with systemic corticosteroids. Br J Dematol 1976;95:181-86.
4. Biancine JR, Macaraeg PV Jr, Lasagna L, Azarnoff DL, Brunk SF, Hvidberg EF, et al. Drugs as etiological factors in Stevens Johnson syndrome. Am J Ophthalmol 1968;44:390-405.
5. Bottinger LE, Strandberg I, Westernholm B. Drug-induced febrile mucocutaneous syndrome: With a review of literature. Acta Med Scand 1975;198:229-33.
6. Yetiv JZ, Bianchieve JR, Ower JA Jr. Etiologic factors in the Stevens Johnson syndrome. South Med J 1980;73:599-602.
7. Howard GM. The Stevens Johnson syndrome. Ocular prognosis and treatment. Am J Ophthalmol 1963;55:893-900.
8. Wright P, Collin JR. The ocular complications of erythema multiforme (Stevens Johnson syndrome) and their management. Trans Ophthalmol Soc UK 1983;103:338-41.
9. Honavar SG, Bansal AK, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 2000;107:975-79.
10. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal neurolysis and Stevens Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991;127:839-42.
11. Foster CS, Fong LP, Azar D, Kenyon KR. Episodic conjunctival inflammation after Stevens Johnson syndrome. Ophthalmology 1988;95:453-62.
12. Prendiville JS, Herbert AA, Greenwald Mj, Esterly MD. Management of Stevens Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989;115:881-87.
13. Mondino B. Cicatricial pemphigoid and erythema multiforme. Ophthalmology 1990;97:939-52.
14. Baum J. Clinical manifestations of dry eye states. Trans Ophthalmol Soc UK 1985;104:415-23.
15. Tabbara K, Shammas H. Bilateral corneal perforations in Stevens Johnson syndrome. Can J Ophthalmol 1975;10:514-17.
16. Tutkun IT, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995;102:576-85.